And it balanced the expression of inflammatory cytokines by inhibiting M1 macrophage polarization, promoting M2 macrophage polarization, and modulating the TLR4/NF-κB signaling pathway to alleviate IBD in mice. This evidence concerns the gene NFKB1 and inflammatory bowel disease.